Hodges Capital Management’s BioTelemetry, Inc. BEAT Stock Holding History

Hodges Capital Management’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-46,285	Closed	-$2.9M	–	245
2019 Q1	$2.9M	Buy	46,285 +11,415	+33%	+$784K	0.29%	94
2018 Q4	$2.08M	Buy	+34,870	New	+$2.09M	0.23%	91
2018 Q3	–	Sell	-40,905	Closed	-$1.84M	–	279
2018 Q2	$1.84M	Sell	40,905 -142,840	-78%	-$5.7M	0.14%	126
2018 Q1	$5.71M	Sell	183,745 -135,245	-42%	-$4.45M	0.45%	60
2017 Q4	$9.54M	Sell	318,990 -108,950	-25%	-$3.15M	0.7%	51
2017 Q3	$14.1M	Sell	427,940 -12,105	-3%	-$419K	0.95%	34
2017 Q2	$14.7M	Buy	+440,045	New	+$13.1M	0.87%	38

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Hodges Capital Management's BEAT Position: Q2 2019 in Review

Hodges Capital Management sold out of BioTelemetry, Inc. (BEAT) in Q2 2019, closing a stake of 46,285 shares — an estimated $2.9M sold.

Hodges Capital Management first reported a position in BEAT in Q2 2017 and held it in 7 quarters. The position peaked at $14.7M in Q2 2017. 251 funds tracked by Wall St. Rank hold BEAT as of Q2 2019.

Hodges Capital Management reported no remaining BioTelemetry, Inc. position as of Q2 2019 after selling out during the quarter.
Hodges Capital Management sold 46,285 BioTelemetry, Inc. shares in Q2 2019, an estimated $2.9M.
Hodges Capital Management first reported a position in BioTelemetry, Inc. in Q2 2017 and held it in 7 quarters.
Hodges Capital Management's BioTelemetry, Inc. position peaked at $14.7M in Q2 2017.
251 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q2 2019.

Based on Hodges Capital Management's 13F filing for Q2 2019, filed 22 Aug 2019.